FDA Approval: CELLCEPT (MYCOPHENOLATE MOFETIL) — Type 1 - New Molecular Entity
Policy FDA-NDA050722 · Multi-specialty
New FDA drug approval. Coverage and billing pathway depend on the FDA label and applicable Medicare LCDs/NCDs — for very recent approvals the label may not be posted yet. Verify against the FDA label and current coverage policy before billing.